• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
Home
  • Research
  • Biotech
    • Clinical Data
    • Venture Capital
    • Deals
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending Topics
    • Cell & Gene Therapy
    • COVID-19
    • Emerging Biopharma
  • Podcasts
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
Search Icon
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Research
  • Biotech
    • Clinical Data
    • Venture Capital
    • Deals
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending Topics
    • Cell & Gene Therapy
    • COVID-19
    • Emerging Biopharma
  • Podcasts
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events

failed trials

Biotech

Ocuphire's diabetic eye drug misses phase 2 primary endpoint

Ocuphire Pharma’s diabetic retinopathy candidate missed the primary endpoint of a phase 2 trial, sending the company’s shares down over 25%.
James Waldron Jan 26, 2023 8:32am

J&J packs up HIV vaccine after failing phase 3 trial

Jan 18, 2023 10:44am

Irlab's Ipsen-partnered Parkinson's drug flunks phase 2 trial

Jan 18, 2023 10:08am

Oramed’s oral insulin flunks phase 3 diabetes test

Jan 12, 2023 6:30am

Merck bails on NGM eye disease collab in wake of trial failure

Dec 21, 2022 9:09am

'Uninterpretable' phase 3 results stymie ContraFect

Dec 20, 2022 1:18pm
Home
  • Connect
    • The Team
    • Advertise
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2023 Questex LLC All rights reserved.
Terms of use
Privacy Policy